Akari Therapeutics Plc (AKTX)

0.2672 +0.02 (+8.93%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Akari Therapeutics Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade